Foregut diseases: foregut neoplasms
Authors:
prof. MUDr. DrSc. Miloslav Duda 1; MUDr. Ph.D. Štěpán Suchánek 2; MUDr. Lukáš Adamčík 3; MUDr. Tomáš Jínek 3
Authors place of work:
II. chirurgická klinika LF UP a FN Olomouc a Chirurgické oddělení a Komplexní onkologické centrum, Nemocnice Nový Jičín, a. s.
1; Interní klinika 1. LF UK a ÚVN Praha
2; Chirurgické oddělení a Komplexní onkologické centrum, Nemocnice Nový Jičín, a. s.
3
Published in the journal:
Čas. Lék. čes. 2016; 155: 23-29
Category:
Review Articles
Summary
The diseases esophagus, stomach and duodenum are more frequently described as the foregut diseases. This term arises from the common embryologic origin of this part of the gastrointestinal (GI) tract. Therefore similar diagnostic approach, surgical therapy and possible secondary prevention are recommended.
The concept of foregut surgery has been used for many years in USA and western countries mainly among surgeons and gastroenterologist, especially i the management of patients with upper GI tract malignancies.
In the Czech Republic, there were 2,204 patients diagnosed yearly with foregut cancers in years 2006–2010. These carcinomas are the second most common solid GI malignancies, following colorectal cancer (8,127 yearly). Among all cancers they occupy the fourth position in incidence after colorectal cancer, breast cancer (6,371 yearly) and lung cancer (6,782 yearly). Regarding the numbers of surgically treated cancers, they rank the third position. The late clinical stage diagnosis is associated with low five year survival (18 % esophagus; 30 % stomach).
Therefore, it is necessary to search for better early endoscopic diagnosis. In case of surgery, the improvement is possible by using the high volume hospitals principle.
Keywords:
foregut diseases, foregut surgery, foregut oncology, early diagnosis, „high volume hospitals” principle
Zdroje
1. oregonclinic.com/specialties/foregut-surgery
2. sofisite.com
3. urmc.rochester.edu/surgery/thoracic.aspx
4. swedish.org/foregut-oncology-program
5. Peters JH, DeMester TR (eds.). Minimally invasive surgery of the foregut. Quality Medical Publishing, Inc., St. Louis Missouri, 1994.
6. Hochwald SN (ed.). Minimally invasive foregut surgery for Malignancy. Springer International Publishing, 2015
7. http://foregutdiseasefoundation.org
8. Národní onkologický registr (NOR) České republiky, Systém pro vizualizaci onkologických dat (SVOD). URL: www.cba.muni.cz/svod
9. Duda M, Žaloudík J, Ryska M, Dušek L. Surgical Onkology. In Dušek L et al. Czech cancer care in number 2008−2009. Grada Publishing, Praha, 2009, p. 283–291.
10. Duda M, Žaloudík J, Ryska M, Dušek L. Chirurgická léčba solidních nádorů v České republice. Rozhl Chir 2010; 89(10): 588–593.
11. Martínek J, Falt P, Gregar J et al. Standardy České gastroenterologické společnosti – endoskopická léčba pacientů s Barrettovým jícnem a časnými neopláziemi jícnu. Gastroent Hepatol 2013; 67(6): 479–487.
12. Vítek P, Komínek P, Kajzrlíková I et al. Endoskopická diagnostika a léčba časného spinocelulárního karcinomu jícnu je možná i v populaci s nízkou incidencí tohoto onemocnění. Endoskopie 2009; 18(4): 161–166.
13. Dimick JB, Wainess R, Upchurch G et al. National trends in outcomes for esophageal resection. An Thorac Surg 2005; 79: 212–218.
14. Wenner J, Zilling T, Bladstroom A, Alvegard TA. The influence of surgical volume on hospital mortality and 5year survival for carcinoma of the eosophagus and gastric cardia. Anticancer Res 2005; 25: 419–424.
15. Wouters MW, Wijnhoven BP, Karim-Kos HE et al. High-volume versus low-volume for esophageal resection for cancer: the essentials role of case mix adjustments based on clinical data. Ann Surg Oncol. 2008;15:80–87.
16. Metzger R, Bollshweiler E, Vallböhmer D et al. High volume centers for esophagectomy: what is the number needed to achive low postoperative mortality? Dis Esophagus 2004; 17: 310–314.
17. Wenner J, Zilling T, Bladstroom A, Alvegard TA. The influence of surgical volume on hospital mortality and 5year survival for carcinoma of the eosophagus and gastric cardia. Anticancer Res 2005; 25: 419–424.
18. Stavrou EP, Smith GS, Baker DF. Surgical outcomes associated with oesophagectomy in New South Wales: an investigation of hospital volume. J Gastrointest Surg 2010; 14: 951–957.
19. Verhoef C, van de Weyer R, Schaapveld M et al. Better survival in patiens with esophageal cancer after surgical treatment in university hospitals: a plea for performance by surgical oncologist. Ann Surg Oncol 2007; 14: 1678–1687.
20. Thompson AM, Rapson T, Gilbert FG, Park KGM. Hospital volume does not influence long- term survival of patiens undergoing surgery for oesophageal or gastric cancer. Br J Surg 2007; 94: 578–584.
21. Dimick JB, Pronovost PJ, Cowan JA jr., Lipsett PA. Surgical volume and quality of care for esophageal resection: do high-volume hospitals have fewer complications? Ann Thorac Surg 2003; 75: 337–341.
22. Coupland VH, Lagergren J, Lüchtenborg M et al. Hospital volume, proportion resected and mortality from oesophageal and gastric cancer: a population-based study in England, 2004–2008. Gut 2013; 62: 961–966.
23. Dikken JL, Stiekema J, van de Velde CJ et al. Quality of care indicators for the surgical treatment of gastric cancer: a systematic review. Ann Surg Oncol 2013; 20: 381–398.
24. Dikken JL, Wouters MW, Lemmens VE et al. Influence of hospital type on outcomes after oesophageal and gastric cancer surgery. Br J Surg 2012; 99: 954–963.
25. Anderson O, Ni Z, Møller H et al. Hospital volume and survival in oesophagectomy and gastrectomy for cancer. Eur J Cancer 2011; 47: 2408–2414.
26. Wahnschaff F, Clauer U, Roder J. Surgery of gastric cancer in a medium volume center. Chirurg 2012; 83(9): 823–829.
27. Reavis KM, Hinojosa MW, Smith BR et al. Hospital volume is not a predictor of outcomes after gastrectomy for neoplasm. Am Surg 2009; 75(10): 932–936.
28. Dixon M, Mahar A, Paszat L et al. What provider volumes and characteristics are appropriate for gastric cancer resection? Results of an international RAND/UCLA expert panel. Surgery 2013; 154(5): 1100–1109.
29. Schüttzner J. Registr hrudních výkonů v České republice 2007−2014. Nepublikované sdělení, 2014.
Štítky
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management Dental HygienistČlánok vyšiel v časopise
Journal of Czech Physicians
- Advances in the Treatment of Myasthenia Gravis on the Horizon
- Spasmolytic Effect of Metamizole
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- What Effect Can Be Expected from Limosilactobacillus reuteri in Mucositis and Peri-Implantitis?
- Metamizole in perioperative treatment in children under 14 years – results of a questionnaire survey from practice
Najčítanejšie v tomto čísle
- Pancreatic cancer – current effective diagnostic and therapeutic approach
- Malignant biliary obstruction
- Professor Josef Marek - octogenarian
- Foregut diseases: foregut neoplasms